Nuclear receptor NR5A2 negatively regulates cell proliferation and tumor growth in nervous system malignancies.
Ontology highlight
ABSTRACT: Nervous system malignancies are characterized by rapid progression and poor survival rates. These clinical observations underscore the need for novel therapeutic insights and pharmacological targets. To this end, here, we identify the orphan nuclear receptor NR5A2/LRH1 as a negative regulator of cancer cell proliferation and promising pharmacological target for nervous system-related tumors. In particular, clinical data from publicly available databases suggest that high expression levels of NR5A2 are associated with favorable prognosis in patients with glioblastoma and neuroblastoma tumors. Consistently, we experimentally show that NR5A2 is sufficient to strongly suppress proliferation of both human and mouse glioblastoma and neuroblastoma cells without inducing apoptosis. Moreover, short
SUBMITTER: Gkikas D
PROVIDER: S-EPMC8488649 | biostudies-literature | 2021 Sep
REPOSITORIES: biostudies-literature
ACCESS DATA